G

Genome Opinion

10 employees

Genome Opinion develops clinical-level drugs driven by novel biomarkers.

Basic info

Industry

biotechnology research

Sectors

Health Care
Omics
Therapeutics
Diagnostic
Medical
Pharmaceutical
Bioinformatics
Precision Medicine

Date founded

2017

Funding rounds raised

G

Genome Opinion raised undisclosed on February 1, 2018

Investors: TIPS Town

FAQ